Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By Surgery

NCT00305877 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

137

Enrollment

NIH

Sponsor class

Conditions

Stage IA Pancreatic Cancer
Stage IB Pancreatic Cancer
Stage IIA Pancreatic Cancer
Stage IIB Pancreatic Cancer

Interventions

BIOLOGICAL: cetuximab
DRUG: gemcitabine hydrochloride
DRUG: capecitabine
RADIATION: radiation therapy
BIOLOGICAL: bevacizumab
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)